Extensive Market Presence VIDAL's solutions are embedded in the healthcare system of France, reaching nearly all physicians, pharmacists, and over 90% of hospitals, indicating a strong market foothold and high user engagement.

Growth through Partnerships Recent partnership with Datapharm enhances VIDAL's data accessibility and credibility, paving the way for expansion into new markets and strengthening its position as a trusted healthcare information provider.

Acquisition Backing Being owned by M3 USA Corporation since 2016 provides VIDAL with substantial financial backing and strategic resources, which can support scalable product development and international growth initiatives.

Digital Expertise With a tech stack that includes digital tools like PWA, GitLab, and web/mobile integrations, VIDAL demonstrates technological sophistication, offering opportunities to upsell advanced digital solutions and integration services.

Significant Revenue Potential Generating between $100M and $250M in revenue, VIDAL presents a sizable client base and revenue stream, offering upselling and cross-selling opportunities for complementary healthcare IT solutions and services.